GENTAMICIN SULFATE (gentamicin sulfate/PF)
AMINOGLYCOSIDES, PARENTERAL · SEPSIS CAUSED BY ENTEROBACTER ·+63
FRESENIUS KABI
Drug class
Aminoglycosides, Parenteral
Parenteral aminoglycosides are a class of potent, intravenously or intramuscularly administered antibacterial agents—primarily including gentamicin, tobramycin, and amikacin—used for systemic therapy. Read more about Aminoglycosides, Parenteral
31 drugs in this class 23 manufacturers
Drugs in Aminoglycosides, Parenteral
GENTAMICIN SULFATE (gentamicin sulfate/PF)
AMINOGLYCOSIDES, PARENTERAL · SEPSIS CAUSED BY ENTEROBACTER ·+63
Hospira
AMIKACIN SULFATE
AMINOGLYCOSIDES, PARENTERAL · STAPHYLOCOCCAL SEPTICEMIA ·+60
Hikma Pharmaceuticals USA
AMIKACIN (amikacin sulfate)
AMINOGLYCOSIDES, PARENTERAL · STAPHYLOCOCCAL SEPTICEMIA ·+60
FRESENIUS KABI
ZEMDRI (plazomicin sulfate)
AMINOGLYCOSIDES, PARENTERAL · COMPLICATED PROTEUS UTI ·+3
CIPLA USA, INC.
ZEMDRI (plazomicin sulfate)
AMINOGLYCOSIDES, PARENTERAL · COMPLICATED PROTEUS UTI ·+3
CIPLA THERAPEUT
TOBRAMYCIN SULFATE
AMINOGLYCOSIDES, PARENTERAL · E. COLI SEPTICEMIA ·+44
NORTHSTAR RX LL
GENTAMICIN SULFATE
AMINOGLYCOSIDES, PARENTERAL · SEPSIS CAUSED BY ENTEROBACTER ·+63
EUGIA US LLC
TOBRAMYCIN SULFATE
AMINOGLYCOSIDES, PARENTERAL · E. COLI SEPTICEMIA ·+44
SLATE RUN PHARM
Filter & compare in the drug finder →
Opens the drug finder with Aminoglycosides, Parenteral preselected. Add indication or manufacturer filters there.
Parenteral aminoglycosides are a class of potent, intravenously or intramuscularly administered antibacterial agents—primarily including gentamicin, tobramycin, and amikacin—used for systemic therapy.
They exert concentration-dependent bactericidal action by crossing bacterial membranes and binding irreversibly to the 30S ribosomal subunit, which disrupts mRNA translation, causes mistranslation of proteins, and compromises the integrity of the bacterial cell envelope.
Clinically, these parenteral formulations serve as vital therapeutic options for severe, life-threatening systemic infections, including sepsis, complicated intra-abdominal infections, complicated urinary tract infections, hospital-acquired pneumonia, and infective endocarditis, predominantly targeting aerobic Gram-negative bacilli or working synergistically against select Gram-positive pathogens.
-
nih.gov
Parenteral aminoglycosides are a class of potent, intravenously or intramuscularly administered antibacterial agents—primarily including gentamicin, tobramycin, and amikacin—used for systemic therapy They exert concentration-dependent bactericidal action by crossing bacterial membranes and binding irreversibly to the 30S ribosomal subunit, which disrupts mRNA translation, causes mistranslation of proteins, and compromises the integrity of the bacterial cell envelope Clinically, these parenteral ...
-
nih.gov
Parenteral aminoglycosides are a class of potent, intravenously or intramuscularly administered antibacterial agents—primarily including gentamicin, tobramycin, and amikacin—used for systemic therapy They exert concentration-dependent bactericidal action by crossing bacterial membranes and binding irreversibly to the 30S ribosomal subunit, which disrupts mRNA translation, causes mistranslation of proteins, and compromises the integrity of the bacterial cell envelope Clinically, these parenteral ...
-
nih.gov
They exert concentration-dependent bactericidal action by crossing bacterial membranes and binding irreversibly to the 30S ribosomal subunit, which disrupts mRNA translation, causes mistranslation of proteins, and compromises the integrity of the bacterial cell envelope
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.